Tumor-associated epilepsy and glioma: Are there common genetic pathways?

Acta Oncologica

Volumn 48, Issue 7, 2009, Pages 955-963

  Berntsson, Shala Ghaderi ^a   Malmer, Beatrice ^b   Bondy, Melissa L ^c   Qu, Mingqi ^a,d   Smits, Anja ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; GLUTAMIC ACID; NEUROTROPHIC FACTOR; SEROTONIN; SEROTONIN TRANSPORTER;

CELL CYCLE REGULATION; DNA REPAIR; FOCAL EPILEPSY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENETICS; GLIOMA; HUMAN; IMMUNE RESPONSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SEIZURE; SYNAPTIC TRANSMISSION; TEMPORAL LOBE EPILEPSY;

BRAIN NEOPLASMS; EPILEPSIES, PARTIAL; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HUMANS; LINKAGE (GENETICS); POLYMORPHISM, GENETIC;

EID: 70350062336     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.1080/02841860903104145     Document Type: Review

References (74)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;/114:/97-109.
2. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol 2005;/109:/93-108.
3. Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: Current concepts and review of the literature. Neuro Oncol 2002;/4:/278-99.
4. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;/352:/987-96.
5. Malmer B, Adatto P, Armstrong G, Barnholtz-Sloan J, Bernstein JL, Claus E, et al. GLIOGENE an International Consortium to Understand Familial Glioma. Cancer Epidemiol Biomarkers Prev 2007;/16:/1730-4.
6. Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'yasova D, et al. Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium. Cancer 2008;/113:/1953-68.
7. Brenner AV, Butler MA, Wang SS, Ruder AM, Rothman N, Schulte PA, et al. Single-nucleotide polymorphisms in selected cytokine genes and risk of adult glioma. Carcinogenesis 2007;/28:/2543-7.
8. Rajaraman P, Wang SS, Rothman N, Brown MM, Black PM, Fine HA, et al. Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev 2007;/16:/1655-61.
9. Liu Y, Scheurer ME, El-Zein R, Cao Y, Do KA, Gilbert M, et al. Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev 2009;/18:/204-14.
10. Carpentier C, Lejeune J, Gros F, Everhard S, Marie Y, Kaloshi G, et al. Association of telomerase gene hTERT polymorphism and malignant gliomas. J Neurooncol 2007;/ 84:/249-53.
11. Costa BM, Ferreira P, Costa S, Canedo P, Oliveira P, Silva A, et al. Association between functional EGF-61 polymorphism and glioma risk. Clin Cancer Res 2007;/13:/ 2621-2626
12. Lu Z, Cao Y, Wang Y, Zhang Q, Zhang X, Wang S, et al. Polymorphisms in the matrix metalloproteinase-1, 3, and 9 promoters and susceptibility to adult astrocytoma in northern China. J Neurooncol 2007;/85:/65-73.
13. Parhar P, Ezer R, Shao Y, Allen JC, Miller DC, Newcomb EW. Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas. Mol Brain Res 2005 13;137:98-103.
14. Bhowmick DA, Zhuang Z, Wait SD, Weil RJ. A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease. Cancer Res 2004;/64:/ 1220-1223
15. Wrensch M, Kelsey KT, Liu M, Miike R, Moghadassi M, Aldape K, et al. Glutathione-S-transferase variants and adult glioma. Cancer Epidemiol Biomarkers Prev 2004;/13:/461-7.
16. Wang LE, Bondy ML, Shen H, El-Zein R, Aldape K, Cao Y, et al. Polymorphisms of DNA repair genes and risk of glioma. Cancer Res 2004;/64:/5560-3.
17. Frigerio S, Ciusani E, Pozzi A, Silvani A, Salmaggi A, Boiardi A. Tumor necrosis factor microsatellite polymorphisms in Italian glioblastoma patients. Cancer Genet Cytogenet 1999;/109:/172-4.
18. Bethke L, Webb E, Murray A, Schoemaker M, Johansen C, Christensen HC, et al. Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet 2008;/17:/800-5.
19. McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, Ruder AM, Butler M, Rajaraman P, et al. Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev 2009;/18:/1118-26.
20. Wiemels JL, Wiencke JK, Kelsey KT, Moghadassi M, Rice T, Urayama KY, et al. Allergy-related polymorphisms influence glioma status and serum IgE levels. Cancer Epidemiol Biomarkers Prev 2007;/16:/1229-35.
21. Scheurer ME, Amirian E, Cao Y, Gilbert MR, Aldape KD, Kornguth DG, et al. Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma. Clin Cancer Res 2008;/14:/6640-6.
22. Beaumont A, Whittle IR. The pathogenesis of tumour associated epilepsy. Acta Neurochir (Wien) 2000;/142:/1-15.
23. Schaller B, Ruegg SJ. Brain tumor and seizures: Pathophysiology and its implications for treatment revisited. Epilepsia 2003;/44:/1223-32.
24. Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, et al. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 2008;/108:/227-35.
25. Rosati A, Tomassini A, Pollo B, Ambrosi C, Schwarz A, Padovani A, et al. Epilepsy in cerebral glioma: Timing of appearance and histological correlations. J Neurooncol 2009 Jan 29 [Epub ahead of print]
26. van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: Epidemiology, mechanisms, and management. Lancet Neurol 2007;/6:/421-30.
27. Piepmeier J, Christopher S, Spencer D, Byrne T, Kim J, Knisel JP, et al. Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 1996;/38:/872-8.
28. Danfors T, Ribom R, Ghaderi Berntsson S, Smits A. Epileptic seizures and survival during early disease in grade 2 gliomas. Eur J Neurol 2009 (in press).
29. Kalachikov S, Evgrafov O, Ross B, Winawer M, Barker- Cummings C, Martinelli Boneschi F, et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 2002;/30:/335-41.
30. Hayman M, Scheffer IE, Chinvarun Y, Berlangieri SU, Berkovic SF. Autosomal dominant nocturnal frontal lobe epilepsy: Demonstration of focal frontal onset and intrafamilial variation. Neurology 1997;/49:/969-75.
31. Phillips HA, Scheffer IE, Berkovic SF, Hollway GE, Sutherland GR, Mulley JC. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2. Nat Genet 1995;/10:/117-8.
32. Cavalleri GL, Lynch JM, Depondt C, Burley MW, Wood NW, Sisodiya SM, et al. Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: Where to from here? Brain 2005;/128:/1832-40.
33. Kanemoto K, Kawasaki J, Miyamoto T, Obayashi H, Nishimura M. Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol 2000;/47:/571-4.
34. Kanemoto K, Kawasaki J, Yuasa S, Kumaki T, Tomohiro O, Kaji R, et al. Increased frequency of interleukin-1beta-511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia 2003;/ 44:/796-9.
35. Ozkara C, Uzan M, Tanriverdi T, Baykara O, Ekinci B, Yeni N, et al. Lack of association between IL-1beta/alpha gene polymorphisms and temporal lobe epilepsy with hippocampal sclerosis. Seizure 2006;/15:/288-91.
36. Heils A, Haug K, Kunz WS, Fernandez G, Horvath S, Rebstock J, et al. Interleukin-1beta gene polymorphism and susceptibility to temporal lobe epilepsy with hippocampal sclerosis. Ann Neurol 2000;/48:/948-50.
37. Buono RJ, Ferraro TN, O'Connor MJ, Sperling MR, Ryan SG, Scattergood T, et al. Lack of association between an interleukin 1 beta (IL-1beta) gene variation and refractory temporal lobe epilepsy. Epilepsia 2001;/42:/782-4.
38. Jin L, Jia Y, Zhang B, Xu Q, Fan Y, Wu L, Shen Y. Association analysis of a polymorphism of interleukin 1 beta (IL-1 beta) gene with temporal lobe epilepsy in a Chinese population. Epilepsia 2003;/44:/1306-9.
39. Gambardella A, Manna I, Labate A, Chifari R, La Russa A, Serra P, et al. GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy. Neurology 2003;/60:/560-3. (Pubitemid 36246069)
40. Ma S, Abou-Khalil B, Sutcliffe JS, Haines JL, Hedera P. The GABBR1 locus and the G1465A variant is not associated with temporal lobe epilepsy preceded by febrile seizures. BMC Med Genet 2005;/6:/13.
41. Ma S, Abou-Khalil B, Blair MA, Sutcliffe JS, Haines JL, Hedera P. Mutations in GABRA1, GABRA5, GABRG2 and GABRD receptor genes are not a major factor in the pathogenesis of familial focal epilepsy preceded by febrile seizures. Neurosci Lett 2006;/394:/74-8.
42. Manna I, Labate A, Gambardella A, Forabosco P, La Russa A, Le Piane E, et al. Serotonin transporter gene (5-Htt): Association analysis with temporal lobe epilepsy. Neurosci Lett 2007;/421:/52-6. (Pubitemid 46908862)
43. Blumcke I, Brockhaus A, Scheiwe C, Rollbrocker B, Wolf HK, Elger CE, et al. The apolipoprotein E epsilon 4 allele is not associated with early onset temporal lobe epilepsy. Neuroreport 1997;/8:/1235-7.
44. Gambardella A, Aguglia U, Cittadella R, Romeo N, Sibilia G, LePiane E, et al. Apolipoprotein E polymorphisms and the risk of nonlesional temporal lobe epilepsy. Epilepsia 1999;/40:/1804-7.
45. Yeni SN, Ozkara C, Buyru N, Baykara O, Hanoglu L, Karaagac N, et al. Association between APOE polymorphisms and mesial temporal lobe epilepsy with hippocampal sclerosis. Eur J Neurol 2005;/12:/103-7.
46. Briellmann RS, Torn-Broers Y, Busuttil BE, Major BJ, Kalnins RM, Olsen M, et al. APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology 2000;/55:/435-7.
47. Kanemoto K, Kawasaki J, Tarao Y, Kumaki T, Oshima T, Kaji R, et al. Association of partial epilepsy with brainderived neurotrophic factor (BDNF) gene polymorphisms. Epilepsy Res 2003;/53:/255-8.
48. Lohoff FW, Ferraro TN, Dahl JP, Hildebrandt MA, Scattergood TM, O'Connor MJ, et al. Lack of association between variations in the brain-derived neurotrophic factor (BDNF) gene and temporal lobe epilepsy. Epilepsy Res 2005;/66:/59-62.
49. Loacker S, Sayyah M, Wittmann W, Herzog H, Schwarzer C. Endogenous dynorphin in epileptogenesis and epilepsy: Anticonvulsant net effect via kappa opioid receptors. Brain 2007;/130:/1017-28.
50. Stogmann E, Zimprich A, Baumgartner C, Aull-Watschinger S, Hollt V, Zimprich F. A functional polymorphism in the prodynorphin gene promotor is associated with temporal lobe epilepsy. Ann Neurol 2002;/51:/260-3.
51. Walz R, Castro RM, Velasco TR, Alexandre V, Jr., Lopes MH, Leite JP, et al. Surgical outcome in mesial temporal sclerosis correlates with prion protein gene variant. Neurology 2003;/61:/1204-10.
52. Whittle IR, Sellar R, Ironside JW. Epileptogenic anaplastic astrocytoma imaged only by T2-weighted magnetic resonance studies: Clinical and surgical implications. Br J Neurosurg 1992;/6:/537-42.
53. Chao CC, Molitor TW, Hu S. Neuroprotective role of IL-4 against activated microglia. J Immunol 1993;/151:/1473-81.
54. Scanziani M, Debanne D, Muller M, Gahwiler BH, Thompson SM. Role of excitatory amino acid and GABAB receptors in the generation of epileptiform activity in disinhibited hippocampal slice cultures. Neuroscience 1994;/ 61:/823-32.
55. Mangan PS, Lothman EW. Profound disturbances of preand postsynaptic GABAB-receptor-mediated processes in region CA1 in a chronic model of temporal lobe epilepsy. J Neurophysiol 1996;/76:/1282-96.
56. Schuler V, Luscher C, Blanchet C, Klix N, Sansig G, Klebs K, et al. Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). Neuron 2001;/31:/47-58.
57. Han Z, Slack RS, Li W, Papadopoulos V. Expression of peripheral benzodiazepine receptor (PBR) in human tumors: Relationship to breast, colorectal, and prostate tumor progression. J Recept Signal Transduct Res 2003;/23:/225-38.
58. Veenman L, Levin E, Weisinger G, Leschiner S, Spanier I, Snyder SH, et al. Peripheral-type benzodiazepine receptor density and in vitro tumorigenicity of glioma cell lines. Biochem Pharmacol 2004;/68:/689-98.
59. Vlodavsky E, Soustiel JF. Immunohistochemical expression of peripheral benzodiazepine receptors in human astrocytomas and its correlation with grade of malignancy, proliferation, apoptosis and survival. J Neurooncol 2007;/81:/1-7.
60. Bjurstöm H, Wang J, Ericsson I, Bengtsson M, Liu Y, Kumar-Mendu S, et al. GABA, a natural immunomodulator of T lymphocytes. J Neuroimmunol 2008;/205:/44-50.
61. Jobe PC, Dailey JW, Wernicke JF. A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit Rev Neurobiol 1999;/13:/317-56.
62. Noda M, Higashida H, Aoki S, Wada K. Multiple signal transduction pathways mediated by 5-HT receptors. Mol Neurobiol 2004;/29:/31-9.
63. Hisaoka K, Nishida A, Takebayashi M, Koda T, Yamawaki S, Nakata Y. Serotonin increases glial cell line-derived neurotrophic factor release in rat C6 glioblastoma cells. Brain Res 2004;/1002:/167-70.
64. Binder DK, Steinhauser C. Functional changes in astroglial cells in epilepsy. Glia 2006;/54:/358-68.
65. Sontheimer H. A role for glutamate in growth and invasion of primary brain tumors. J Neurochem 2008;/105:/287-95.
66. Lyons SA, Chung WJ, Weaver AK, Ogunrinu T, Sontheimer H. Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res 2007;/67:/9463-71.
67. Barde YA. Trophic factors and neuronal survival. Neuron 1989;/2:/1525-34.
68. Aronica E, Leenstra S, Jansen GH, van Veelen CW, Yankaya B, Troost D. Expression of brain-derived neurotrophic factor and tyrosine kinase B receptor proteins in glioneuronal tumors from patients with intractable epilepsy: Colocalization with N-methyl-D-aspartic acid receptor. Acta Neuropathol 2001;/101:/383-92.
69. Aronica E, Boer K, Becker A, Redeker S, Spliet WG, van Rijen PC, et al. Gene expression profile analysis of epilepsyassociated gangliogliomas. Neuroscience 2008;/151:/272-92.
70. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A 1993;/90:/9649-53.
71. Mackenzie IR, Miller LA. Senile plaques in temporal lobe epilepsy. Acta Neuropathol 1994;/87:/504-10.
72. Sheng JG, Boop FA, Mrak RE, Griffin WS. Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: Association with interleukin-1 alpha immunoreactivity. J Neurochem 1994;/63:/1872-9.
73. Nicoll JA, Zunarelli E, Rampling R, Murray LS, Papanastassiou V, Stewart J. Involvement of apolipoprotein E in glioblastoma: Immunohistochemistry and clinical outcome. Neuroreport 2003;/14:/1923-6.
74. Brat DJ, Gearing M, Goldthwaite PT, Wainer BH, Burger PC. Tau-associated neuropathology in ganglion cell tumours increases with patient age but appears unrelated to ApoE genotype. Neuropathol Appl Neurobiol 2001;/27:/197-205.